In obesity-related osteoarthritis, decreased joint compression alone may explain some of the pain improvements reported by patients using GLP-1 medications
these are: LPAC (Low-Phospholipid Associated Cholelithiasis) [17] RIC (Recurrent Intrahepatic Cholestasis) [18] ICP (Intrahepatic Cholestasis of Pregnancy [23] Cofactor of progression in other liver diseases [24] HBC (Hepatobiliary cancer) [9] While in many cases the symptoms of these diseases can be controlled for a long time, in other cases the patient can undergo rapid progression, fibrosis, or cancer [9]
But the stakes are arguably highest in India
Pros and Cons of GLP1 Medications The key takeaway for GLP1 meds pros and cons weight loss is that they offer high efficacy with the benefit of being non-surgical, but require consistent, long-term use
This decision, made by Judge Mark Pittman of the Northern District of Texas, follows a lawsuit filed by the Outsourcing Facilities Association (OFA) in October
Industry analysts project a potential launch in 2028, though timelines could shift depending on regulatory review